Invention Grant
- Patent Title: Prognostic marker for cryoglobulinemic vasculitis and B cell malignancies in HCV infected patients
-
Application No.: US13581759Application Date: 2011-02-28
-
Publication No.: US09719141B2Publication Date: 2017-08-01
- Inventor: Vincent Agnello
- Applicant: Vincent Agnello
- Applicant Address: US MA Weston
- Assignee: Vincent Agnello
- Current Assignee: Vincent Agnello
- Current Assignee Address: US MA Weston
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Agent Ingrid A. Beattie
- International Application: PCT/US2011/026455 WO 20110228
- International Announcement: WO2011/109285 WO 20110909
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C07H21/02 ; C07H21/04 ; G01N33/576 ; G01N33/574 ; G01N33/68 ; C07K16/28
Abstract:
The invention provides methods and compositions for early diagnosis and treatment of a disease associated with a specific antibody by employing the detection of a cross-idiotypic epitope on the specific antibody to detect the cells that produce the antibody before the development of clinical symptoms of the disease.
Public/Granted literature
- US20130052206A1 Prognostic Marker For Cryoglobulinemic Vasculitis And B Cell Malignancies In HCV Infected Patients Public/Granted day:2013-02-28
Information query
